Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

Rule, S. ; Jurczak, W. ; Jerkeman, M. LU ; Rusconi, C. ; Trneny, M. ; Offner, F. ; Caballero, D. ; Joao, C. ; Witzens-Harig, M. and Hess, G. , et al. (2018) In Leukemia 32(8). p.1799-1803
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Leukemia
volume
32
issue
8
pages
1799 - 1803
publisher
Nature Publishing Group
external identifiers
  • pmid:29572505
  • scopus:85044345230
ISSN
0887-6924
DOI
10.1038/s41375-018-0023-2
language
English
LU publication?
yes
id
00f00ed4-fead-45c3-9414-310f0cc12c71
date added to LUP
2018-04-06 08:21:31
date last changed
2025-10-15 19:04:00
@article{00f00ed4-fead-45c3-9414-310f0cc12c71,
  author       = {{Rule, S. and Jurczak, W. and Jerkeman, M. and Rusconi, C. and Trneny, M. and Offner, F. and Caballero, D. and Joao, C. and Witzens-Harig, M. and Hess, G. and Bence-Bruckler, I. and Cho, S. G. and Thieblemont, C. and Zhou, W. and Henninger, T. and Goldberg, J. and Vermeulen, J. and Dreyling, M.}},
  issn         = {{0887-6924}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{1799--1803}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Leukemia}},
  title        = {{Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study}},
  url          = {{http://dx.doi.org/10.1038/s41375-018-0023-2}},
  doi          = {{10.1038/s41375-018-0023-2}},
  volume       = {{32}},
  year         = {{2018}},
}